Citi raised the firm’s price target on Leidos to $136 from $124 and keeps a Buy rating on the shares. The company’s Q3 results were ahead of consensus expectations driven largely by ramping programs in the healthcare segment and successful achievement of incentive fees on past work, the analyst tells investors in a research note. The firm says a “cleaner story continues to emerge.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on LDOS:
- Early notable gainers among liquid option names on October 31st
- Leidos raises FY23 EPS view to $6.80-$7.10 from $6.40-$6.80, consensus $6.68
- Leidos Holdings, Inc. Reports Third Quarter Fiscal Year 2023 Results
- Leidos reports Q3 EPS $2.03, consensus $1.67
- LDOS Earnings this Week: How Will it Perform?
Questions or Comments about the article? Write to editor@tipranks.com